| Written submissions and meetings with stakeholder organisations. | がん
> がん：ほとんどの種類 | 規制上のパートナーシップ
> 規制機関との連携 | We do not communicate with patients directly | National | Regularly | 115055433125 |
| The Hellenic League Against Rheumatism (ELEANA) regularly represents patient interests to national and European regulators through formal consultations, written submissions, participation in policy dialogues, and involvement in European patient advocacy platforms (e.g., EULAR [European Alliance of Associations for Rheumatology] PARE [People with Arthritis/Rheumatism in Europe], EPF [European Patients' Forum], GAfPA [Global Alliance for Patient Access]). | リウマチ性
> リウマチ性疾患：ほとんどの種類 | 規制上のパートナーシップ
> 政策立案者・規制当局との会議への出席・ファシリテーション | 100,000 | National | Regularly | 119025688550 |
| As a member of secondary and tertiary federations representing persons with disabilities and persons with multiple sclerosis, and through our direct engagement with the state, we advocate on behalf of our members. | 神経学的
> 多発性硬化症 | 規制上のパートナーシップ
> 他の医療擁護者と | 1,000 | Regional | Regularly | 115007075579 |
| Submits proposals to the collective "umbrella" body. | レア
> 希少疾患：ほとんどの種類 | 規制上のパートナーシップ
> 他の医療擁護者と | 1,000 | National | Sometimes | 115019806061 |
| Through written submissions to the Ministry, engagement with local Members of Parliament, direct interpersonal contacts, and the Patient Association of Greece. | 神経変性
> アルツハイマー病 | 規制上のパートナーシップ
> 他の医療擁護者と | 1,000 | Regional | Regularly | 115049818475 |
| Through ΕΛΟΔΙ [Ελληνική Ομοσπονδία για τον Διαβήτη - Hellenic Federation for Diabetes]. | 内分泌
> 糖尿病（1型および2型の両方） | 規制上のパートナーシップ
> 他の医療擁護者と | 100 | Regional | Sometimes | 115060878962 |
| The Hellenic League Against Rheumatism (ELEANA) regularly represents patient interests to national and European regulators through formal consultations, written submissions, participation in policy dialogues, and involvement in European patient advocacy platforms (e.g., EULAR [European Alliance of Associations for Rheumatology] PARE [People with Arthritis/Rheumatism in Europe], EPF [European Patients' Forum], GAfPA [Global Alliance for Patient Access]). | リウマチ性
> リウマチ性疾患：ほとんどの種類 | 規制上のパートナーシップ
> 他の医療擁護者と | 100,000 | National | Regularly | 119025688550 |
| AGORA Federation represents patient perspectives through EU-level policy dialogues and consultations, and via participation in European patient advocacy platforms. We contribute input on access, reimbursement, unmet needs, and quality of life across rheumatic and musculoskeletal diseases from a cross-country (Southern Europe) perspective. | リウマチ性
> リウマチ性疾患：ほとんどの種類 | 規制上のパートナーシップ
> 他の医療擁護者と | We do not communicate with patients directly | International | Rarely | 119025711207 |
| Advocacy for patient pharmacotherapy at the Ministry of Health. | ボーン
> 骨粗鬆症 | 政策と法律への影響
> 医療政策と法律に影響を与える | 10,000 | National | Sometimes | 114996725641 |
| National Strategic Plan for CVD [Cardiovascular Disease]. | 心臓血管
> 心臓血管系：ほとんどの種類 | 政策と法律への影響
> 医療政策と法律に影響を与える | 1,000 | National | Rarely | 115006858228 |
| As a member of secondary and tertiary federations representing persons with disabilities and persons with Multiple Sclerosis, and through direct engagement with public authorities, we advocate on behalf of our members by submitting requests for access to therapeutic treatments and therapies, as well as for the protection of their rights vis-à-vis the state. | 神経学的
> 多発性硬化症 | 政策と法律への影響
> 医療政策と法律に影響を与える | 1,000 | Regional | Regularly | 115007075579 |
| We engage in lobbying activities to advance and protect the interests of patients. | 介護者
> 介護者、家族、友人 | 政策と法律への影響
> 医療政策と法律に影響を与える | 100 | National | Rarely | 115047040745 |
| Where consultation processes are available on the relevant websites, we submit our positions, and we also direct formal requests to the Ministries of Health and Labour [in Greece]. | 神経学的
> 多発性硬化症 | 政策と法律への影響
> 医療政策と法律に影響を与える | 1,000 | Regional | Rarely | 115049438439 |
| Through written submissions to the Ministry, engagement with local Members of Parliament, direct interpersonal contacts, and the Patient Association of Greece. | 神経変性
> アルツハイマー病 | 政策と法律への影響
> 医療政策と法律に影響を与える | 1,000 | Regional | Regularly | 115049818475 |
| Wherever public consultations are hosted on the relevant websites, we submit our views. | 神経学的
> 多発性硬化症 | 政策と法律への影響
> 公聴会やパブリックコンサルテーションに参加する | 1,000 | Regional | Rarely | 115049438439 |
| Where consultation processes are available on the relevant websites, we submit our positions, and we also direct formal requests to the Ministries of Health and Labour [in Greece]. | 神経学的
> 多発性硬化症 | 政策と法律への影響
> 公聴会やパブリックコンサルテーションに参加する | 1,000 | Regional | Rarely | 115049438439 |
| AGORA Federation represents patient perspectives through EU-level policy dialogues and consultations, and via participation in European patient advocacy platforms. We contribute input on access, reimbursement, unmet needs, and quality of life across rheumatic and musculoskeletal diseases from a cross-country (Southern Europe) perspective. | リウマチ性
> リウマチ性疾患：ほとんどの種類 | 政策と法律への影響
> 公聴会やパブリックコンサルテーションに参加する | We do not communicate with patients directly | International | Rarely | 119025711207 |
| Through written submissions to the Ministry, engagement with local Members of Parliament, direct interpersonal contacts, and the Patient Association of Greece. | 神経変性
> アルツハイマー病 | 政策と法律への影響
> 国会議員や政治指導者を動員する | 1,000 | Regional | Regularly | 115049818475 |
| AGORA Federation represents patient perspectives through EU-level policy dialogues and consultations, and via participation in European patient advocacy platforms. We contribute input on access, reimbursement, unmet needs, and quality of life across rheumatic and musculoskeletal diseases from a cross-country (Southern Europe) perspective. | リウマチ性
> リウマチ性疾患：ほとんどの種類 | 価格設定と手頃な価格の擁護
> 公正な医薬品価格の実現を推進する | We do not communicate with patients directly | International | Rarely | 119025711207 |
| Advocacy for patient pharmacotherapy at the Ministry of Health. | ボーン
> 骨粗鬆症 | アクセス経路の改善
> 医薬品・医療への公平なアクセスを促進する | 10,000 | National | Sometimes | 114996725641 |
| Advocacy for access to medicines, diagnostic tests, and related services. | レア
> フォン・ヒッペル・リンドウ症候群 | アクセス経路の改善
> 医薬品・医療への公平なアクセスを促進する | 100 | National | Regularly | 115006788497 |
| Advocacy for access to medicines, diagnostic tests, and related services. | レア
> フォン・ヒッペル・リンドウ症候群 | アクセス経路の改善
> 医薬品・医療への公平なアクセスを促進する | 100 | National | Regularly | 115006788497 |
| As a member of secondary and tertiary federations representing persons with disabilities and persons with multiple sclerosis, and through direct engagement with public authorities, we advocate on behalf of our members by submitting requests for access to therapeutic treatments and therapies, as well as for the protection of their rights vis-à-vis the state. | 神経学的
> 多発性硬化症 | アクセス経路の改善
> 医薬品・医療への公平なアクセスを促進する | 1,000 | Regional | Regularly | 115007075579 |
| Issues relating to employment, accessibility, health inequalities, and the management of treatment options. | がん
> がん：ほとんどの種類 | アクセス経路の改善
> 医薬品・医療への公平なアクセスを促進する | 1,000 | National | Regularly | 115058727551 |
| … The Hellenic League Against Rheumatism (ELEANA) contributes patient perspectives on access to treatments, reimbursement, unmet needs, and quality of life in autoimmune rheumatic diseases, both at national level (Greece) and at EU level. | リウマチ性
> リウマチ性疾患：ほとんどの種類 | アクセス経路の改善
> 医薬品・医療への公平なアクセスを促進する | 100,000 | National | Regularly | 119025688550 |
| AGORA Federation represents patient perspectives through EU-level policy dialogues and consultations, and via participation in European patient advocacy platforms. We contribute input on access, reimbursement, unmet needs, and quality of life across rheumatic and musculoskeletal diseases from a cross-country (Southern Europe) perspective. | リウマチ性
> リウマチ性疾患：ほとんどの種類 | アクセス経路の改善
> 医薬品・医療への公平なアクセスを促進する | We do not communicate with patients directly | International | Rarely | 119025711207 |
| … The Hellenic League Against Rheumatism (ELEANA) contributes patient perspectives on access to treatments, reimbursement, unmet needs, and quality of life in autoimmune rheumatic diseases, both at national level (Greece) and at EU level. | リウマチ性
> リウマチ性疾患：ほとんどの種類 | エビデンスに基づく患者の意見
> 患者のインサイトを活用して意思決定に役立てる | 100,000 | National | Regularly | 119025688550 |
| AGORA Federation represents patient perspectives through EU-level policy dialogues and consultations, and via participation in European patient advocacy platforms. We contribute input on access, reimbursement, unmet needs, and quality of life across rheumatic and musculoskeletal diseases from a cross-country (Southern Europe) perspective. | リウマチ性
> リウマチ性疾患：ほとんどの種類 | エビデンスに基づく患者の意見
> 患者のインサイトを活用して意思決定に役立てる | We do not communicate with patients directly | International | Rarely | 119025711207 |
| Patient interests only [to drug regulatory authorities]. | 免疫
> 原発性免疫不全症 | エビデンスに基づく患者の意見
> 患者の体験談や生きた経験のナラティブを活用する | 100 | Regional | Sometimes | 115055418373 |
| Advocacy for access to medicines, diagnostic tests, and related services. | レア
> フォン・ヒッペル・リンドウ症候群 | 診断と薬の配達
> スクリーニングと早期発見のサポート | 100 | National | Regularly | 115006788497 |
| Participation in Ministry committees addressing chronic disease patients, medicinal products, patient rights. | 未指定
> 未指定 | 機関ガバナンス
> 政府の諮問機関における代表性を確保する | 1,000 | National | Rarely | 115060548215 |
| As a member of secondary and tertiary federations representing persons with disabilities and persons with Multiple Sclerosis, and through direct engagement with public authorities, we advocate on behalf of our members by submitting requests for access to therapeutic treatments and therapies, as well as for the protection of their rights vis-à-vis the state. | 神経学的
> 多発性硬化症 | 患者の権利の擁護/生活の質の向上
> 患者体験の保護・改善 | 1,000 | Regional | Regularly | 115007075579 |
| As a member of secondary and tertiary federations representing persons with disabilities and persons with multiple sclerosis, and through direct engagement with public authorities, we advocate on behalf of our members by submitting requests for access to therapeutic treatments and therapies, as well as for the protection of their rights vis-à-vis the state. | 神経学的
> 多発性硬化症 | 患者の権利の擁護/生活の質の向上
> 患者体験の保護・改善 | 1,000 | Regional | Regularly | 115007075579 |
| Issues relating to employment, accessibility, health inequalities, and the management of treatment options. | がん
> がん：ほとんどの種類 | 患者の権利の擁護/生活の質の向上
> 患者体験の保護・改善 | 1,000 | National | Regularly | 115058727551 |
| Advocating for quality of care and quality of life for patients. | がん
> がん：乳房 | 患者の権利の擁護/生活の質の向上
> 生活の質を重視することを推進する | 5,000 | National | Regularly | 115019649379 |
| Advocating for quality of care and quality of life for patients. | がん
> がん：乳房 | 患者の権利の擁護/生活の質の向上
> 生活の質を重視することを推進する | 5,000 | National | Regularly | 115019649379 |
| Issues relating to employment, accessibility, health inequalities, and the management of treatment options. | がん
> がん：ほとんどの種類 | 患者の権利の擁護/生活の質の向上
> 生活の質を重視することを推進する | 1,000 | National | Regularly | 115058727551 |
| AGORA Federation represents patient perspectives through EU-level policy dialogues and consultations, and via participation in European patient advocacy platforms. We contribute input on access, reimbursement, unmet needs, and quality of life across rheumatic and musculoskeletal diseases from a cross-country (Southern Europe) perspective. | リウマチ性
> リウマチ性疾患：ほとんどの種類 | 患者の権利の擁護/生活の質の向上
> 生活の質を重視することを推進する | We do not communicate with patients directly | International | Rarely | 119025711207 |
インタラクション
アクションと支援活動
8 メンション
